LPCN LIPOCINE INC Product Launches 8-K Filing 2024 - Product Launch Lipocine Inc. announced completion of enrollment and dosing in a pivotal study for LPCN 1154 targeting Postpartum Depression (PPD).Get access to all SEC 8-K filings of the LIPOCINE INC